Cardiovascular disease-related parameters and oxidative stress in SHROB rats, a model for metabolic syndrome

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Molinar Toribio, Eunice ^a   Pérez Jiménez, Jara ^a,g   Ramos Romero, Sara ^a,b   Lluís, Laura ^c   Sánchez Martos, Vanessa ^c   Taltavull, Núria ^c   Romeu, Marta ^c   Pazos, Manuel ^d   Méndez, Lucía ^d   Miranda, Aníbal ^e,f   Cascante, Marta ^e,f   Medina, Isabel ^d   Torres, Josep Lluís ^a  

^a INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^d INSTITUTO DE INVESTIGACIONES MARINAS   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

^f INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^g INSTITUTE OF FOOD SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER;

ANIMAL; BLOOD; CARDIOVASCULAR DISEASE; DISEASE MODEL; FEMALE; METABOLIC SYNDROME X; METABOLISM; OXIDATIVE STRESS; PHENOTYPE; RAT; RISK FACTOR;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; FEMALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PHENOTYPE; RATS; RISK FACTORS;

EID: 84905860622     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104637     Document Type: Article

References (44)

1. Grundy SM (2008) Metabolic syndrome pandemic. Arteriosc Thormb Vasc Biol 28: 629-36.
2. Eckel RH, Alberti KGMM, Grundy SM, Zimmet PZ (2010) The metabolic syndrome. The Lancet 375: 2010, 181-83.
3. Festa A, D'Agostino R, Howard G, Mykkännen L, Tracy RP, et al. (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: The insulin resistance atherosclerosis study (IRAS). Circulation 102: 42-47. (Pubitemid 30430551)
4. Armutcu F, Ataymen M, Atmaca H, Gurel A (2008) Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome. Clin Chem Lab Med 46: 785-90. (Pubitemid 351821641)
5. Güclü F, Özmen B, Hekimsoy Z, Kirmaz C (2004) Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome. Biomed Pharmacother 58: 614-18. (Pubitemid 40260386)
6. Zhang BB, Zhou G, Li C (2009) AMPK: An emerging drug target for diabetes and metabolic syndrome. Cell Metabolism 9: 407-16.
7. Castell-Auvi A, Cedó L, Pallarés V, Blay MT, Pinent M, et al. (2012) Procyanidins modify insulinemia by affecting insulin production and degradation. J Nutr Biochem 23: 1565-72.
8. Kimura T, Nakagawa K, Kubota H, Kojima Y, Goto Y, et al. (2007) Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. J Agric Food Chem 55: 5869-5874. (Pubitemid 47092969)
9. Hariri N, Thibault L (2010) High-fat diet-induced obesity in animal models. Nutr Res Rev 23: 270-99.
10. Poudyal H, Panchal S, Brown L (2010) Comparison of purple carrot juice and β-carotene in a high-carbohydrate, high-fat diet-fed rat model of the metabolic syndrome. Br J Nutr 104: 1322-32.
11. Chua SC, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, et al. (1996) Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Sci 271: 994-96. (Pubitemid 26066874)
12. Koletsky S (1973) Obese spontaneously hypertensive rats: a model for study of atherosclerosis. Exp Molec Pathol 19: 53-60.
13. Koletsky S (1975) Animal model of human disease: hypertension, obesity, type 4 hyperlipidemia, vascular disease. Am J Pathol 81: 463-66.
14. Takaya K, Ogawa Y, Hiraoka J, Hosoda K, Yamori Y, et al. (1996) Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nature Genetics 14: 130-31.
15. Ernsberger P, Koletsky RJ, Friedman JE (1999) Molecular pathology in the obese spontaneous hypertensive Koletsky rats: a model of syndrome X. Annals New York Acad Sci 892: 315-18.
16. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity. Circul 120: 1640-45.
17. Ernsberger P, Koletsky RJ (2012) The glucose tolerance test as a laboratory toll with clinical implications. In Glucose Tolerance [S Chackrewarthy, editor] InTech 2012.
18. k) in obese spontaneously hypertensive Koletsky rats (SHROB). J Nutr 128: 2299-2306.
19. Matthews D, Hosker J, Rudenski A, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-9. (Pubitemid 15018832)
20. Buñag RD (1973) Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 34: 279-82.
21. Cohen G, Dembiec D, Marcus J (1970) Measurement of catalase activity in tissue extracts. Anal Biochem 34: 30-38.
22. Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247: 3170-3175.
23. rd ed, pp. 258-265 [HU. Bergmeyer, editor] Weinheim: Verlag Chemie 1983.
24. Wheeler CR, Salzman JA, Elsayed NM, Omaye ST, Korte DW (1990) Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal Biochem 184: 193-199. (Pubitemid 20055611)
25. Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74: 214-26.
26. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
27. Drabkin D, Austin J (1935) Spectrophotometric studies. II. Preparations from washed blood cells; nitric oxide hemoglobin and sulfhemoglobin. J Biol Chem 112: 51-65.
28. Cao G, Booth SL, Sadowski JA, Prior RL (1998) Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am J Clin Nutr 68: 1081-1087. (Pubitemid 28493970)
29. Chaudhuri AR, de Waal EM, Pierce A, Van Remmen H, Ward WF, et al. (2006) A detection of protein carbonyls in aging liver tissue: A fluorescence-based proteomic approach. Mech Ageing Dev 127: 849-861. (Pubitemid 44602141)
30. Méndez L, Pazos M, Gallardo JM, Torres JL, Pérez- Jiménez J, et al. (2013) Reduced protein oxidation in Wistar rats supplemented with marine omega-3 PUFAs. Free Radical Biol Med 55: 8-20.
31. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
32. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52: 302-10.
33. Milne GL, Sánchez CS, Musiek ES, Morrow DJ (2007) Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nature Protocols 2: 221-226. (Pubitemid 47040087)
34. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc C-Appl 57: 283-90.
35. Simes RJ (1986). An improved bonferroni procedure for multiple tests of significance. Biometrika 73: 751-54.
36. Papazzo A, Conlan XA, Lexis L, Lewandowski PA (2011) Differential effects of dietary canola and soybean oil intake on oxidative stress in stroke-prone spontaneously hypertensive rats. Lipids Health Dis 10: 98.
37. Mendizábal Y, Llorens S, Nava E (2011) Reactivity of the aortic and mesenteric arteries from the obese spontenously hypertensive rat: effect of glitazones. Am J Physiol Heart Circ Physiol 301:H1319-30.
38. Mendizábal Y, Llorens S, Nava E (2013) Vasoactive effects of prostaglandins from the perivascular fat of mesenteric resistance arteries in WKY and SHROB rats. Life Sci 93: 1023-32.
39. Fellman L, Nascimento AR, Tibiriça E, Bousquet P (2012) Murine models for pharmacological studies on the metaoblic syndrome. Pharmacol Therapeut 137: 331-40.
40. Samuel VT & Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148: 852-871.
41. Chawla A, Nguyen KD, Goh YPS (2011) Macrophage-.mediated inflammation in metabolic disease. Nat Rev Inmunol 11: 738-49.
42. Maritim AC, Sanders RA, Watkins JB (2003) Diabetes, oxidative stress, and antioxidants: A review. J Biochem Molec Toxicol 17: 24-38. (Pubitemid 36410972)
43. Imig JD, Walsh KA, Khan MA, Nagasawa T, Cherian-Shaw M, et al. (2012) Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats. Exp Biol Med 237: 1402-12.
44. Méndez L, Pazos M, Giralt M, Nogués MR, Pérez-Jiménez J, et al. (2014) Targets of protein carbonylation in Koletsky Spontaneously Hypertensive Obese Rats and healthy Wistar counterparts: a potential role on metabolic disorders. J Proteom 106: 246-59.